Long-Term Follow-up Study of Early Stage Breast Cancer Patients Included in GEICAM Studies
Spanish Breast Cancer Research Group · Complejo Hospitalario de Navarra, Pamplona, Navarre
This is a multicenter, cohorts study to collect information from patients diagnosed with early-stage invasive breast cancer who have been previously included in a neoadjuvant or adjuvant clinical trial of the GEICAM group. Patients will be included in this study from the moment of completion of the follow-up of the studies of origin and will be followed for approximately 30 years
Eligibility: 18 Years to · Female · * Patients included in neoadjuvant and adjuvant clinical trials with GEICAM's participation. If any of these patients had taken part or is participating in another clinical trial, she/he is eligible for this trial and her/his information will also be collected. * Patients whose death or contact loss has not been previously collected in the databases of the original studies.